Hadasit Bio-Holdings Ltd
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings L… Read more
Market Cap & Net Worth: Hadasit Bio-Holdings Ltd (HSITF)
Hadasit Bio-Holdings Ltd (PINK:HSITF) has a market capitalization of $1.33 Million ($1.33 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #38203 globally and #12435 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hadasit Bio-Holdings Ltd's stock price $0.12 by its total outstanding shares 11088500 (11.09 Million).
Hadasit Bio-Holdings Ltd Market Cap History: 2015 to 2025
Hadasit Bio-Holdings Ltd's market capitalization history from 2015 to 2025. Data shows change from $7.19 Million to $1.33 Million (-17.29% CAGR).
Hadasit Bio-Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hadasit Bio-Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
515.08x
Hadasit Bio-Holdings Ltd's market cap is 515.08 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $9.29 Million | $360.00K | $13.17 Million | 25.81x | 0.71x |
| 2018 | $17.74 Million | $250.00K | -$316.00K | 70.97x | N/A |
| 2019 | $11.85 Million | $23.00K | -$22.30 Million | 515.08x | N/A |
Competitor Companies of HSITF by Market Capitalization
Companies near Hadasit Bio-Holdings Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Hadasit Bio-Holdings Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Hadasit Bio-Holdings Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Hadasit Bio-Holdings Ltd's market cap moved from $7.19 Million to $ 1.33 Million, with a yearly change of -17.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.33 Million | -7.69% |
| 2024 | $1.44 Million | -48.00% |
| 2023 | $2.77 Million | -66.67% |
| 2022 | $8.32 Million | -42.31% |
| 2021 | $14.42 Million | -30.48% |
| 2020 | $20.74 Million | +75.03% |
| 2019 | $11.85 Million | -33.23% |
| 2018 | $17.74 Million | +90.93% |
| 2017 | $9.29 Million | +46.50% |
| 2016 | $6.34 Million | -11.73% |
| 2015 | $7.19 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Hadasit Bio-Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.33 Million USD |
| MoneyControl | $1.33 Million USD |
| MarketWatch | $1.33 Million USD |
| marketcap.company | $1.33 Million USD |
| Reuters | $1.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.